welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Tucson drug startup launches gastric-cancer trial
Tucson-based drug startup Cancer Prevention Pharmaceuticals Inc. has announced the launch of a Phase 2 clinical trial at Vanderbilt University Medical Center to test the company’s flagship drug candidate for preventing gastric cancer.
The drug, CPP-1X, will be studied in patients with precancerous gastric lesions who are at high risk for gastric cancer, the company said Monday.
The trial is funded by the National Cancer Institute and run in collaboration with gastroenterologists Dr. Keith T. Wilson and Dr. Douglas R. Morgan of the Vanderbilt University School of Medicine and the Vanderbilt-Ingram Cancer Center.
expertly curated content related to this topic
-
Colonic Manifestationshttp://static-content.springer.com/image...
-
Ileal Pouch and Related Complications: Spectrum of Imaging Findings with Emphasis on MRIProctocolectomy with ileal pouch-anal an...
-
Successful Radiofrequency Ablation of an Anterior Abdominal Wall Desmoid in Familial Adenomatous PolyposisBACKGROUND : Desmoid tumours are an impo...
-
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomicsBackground: Saliva, blood, tissue, and ...
-
New treatment reduces precancerous polyps in hereditary cancer patientsInheriting a mutation in the APC gene le...
-
Familial Adenomatous Polyposishttp://www.gastrointestinalatlas.com/ima...
-
Discrepancies in Biopsy Results in Pre- Versus Post-Endoscopic AmpullectomiesAbstract Purpose: Endoscopic ampullec...